ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, W.
Eur Respir J 1997; 10: 1914-1917
Copyright © ERS Journals Ltd 1997


Original Articles

Lung mucus: a clinician's view

WD Kim

Respiratory mucus represents the products derived from secretion of the submucosal glands and the goblet cells. Accumulation of mucus in the airway tree may be caused by an increased volume of mucus produced, and also by decreased clearance due to defects in the ciliary clearance apparatus. Hypersecretion of mucus contributes to the morbidity of airway diseases by predisposing patients to respiratory infections, and contributing to airflow obstruction and to patients' discomfort. There is a significant association between chronic production of mucus and an increased risk of mortality. Also the degree of airway obstruction is related to the physical properties of the sputum. Observation of chronic bronchitic sputum can reveal important clinical information concerning the type and level of the inflammatory process, the physical properties of the material, the extent of bronchial mucosal damage, and the identification of pathogenic microorganisms that may be present. The management of mucous hypersecretion can be undertaken in two main ways: firstly, improved clearance by physical methods; and, secondly, by pharmacological methods.


This article has been cited by other articles:


Home page
J. Immunol.Home page
U. Ha, J. H. Lim, H. Jono, T. Koga, A. Srivastava, R. Malley, G. Pages, J. Pouyssegur, and J.-D. Li
A Novel Role for I{kappa}B Kinase (IKK) {alpha} and IKKbeta in ERK-Dependent Up-Regulation of MUC5AC Mucin Transcription by Streptococcus pneumoniae
J. Immunol., February 1, 2007; 178(3): 1736 - 1747.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. McMillan, G. Xanthou, and C. M. Lloyd
Manipulation of Allergen-Induced Airway Remodeling by Treatment with Anti-TGF-{beta} Antibody: Effect on the Smad Signaling Pathway
J. Immunol., May 1, 2005; 174(9): 5774 - 5780.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Jono, H. Xu, H. Kai, D. J. Lim, Y. S. Kim, X.-H. Feng, and J.-D. Li
Transforming Growth Factor-{beta}-Smad Signaling Pathway Negatively Regulates Nontypeable Haemophilus influenzae-induced MUC5AC Mucin Transcription via Mitogen-activated Protein Kinase (MAPK) Phosphatase-1-dependent Inhibition of p38 MAPK
J. Biol. Chem., July 18, 2003; 278(30): 27811 - 27819.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Jono, T. Shuto, H. Xu, H. Kai, D. J. Lim, J. R. Gum Jr., Y. S. Kim, S. Yamaoka, X.-H. Feng, and J.-D. Li
Transforming Growth Factor-beta -Smad Signaling Pathway Cooperates with NF-kappa B to Mediate Nontypeable Haemophilus influenzae-induced MUC2 Mucin Transcription
J. Biol. Chem., November 15, 2002; 277(47): 45547 - 45557.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-D. Kim, E.-J. Kwon, D.-W. Park, S.-Y. Song, S.-K. Yoon, and S.-H. Baek
Interleukin-1beta Induces MUC2 and MUC5AC Synthesis through Cyclooxygenase-2 in NCI-H292 Cells
Mol. Pharmacol., November 1, 2002; 62(5): 1112 - 1118.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. J. McMillan, B. Bishop, M. J. Townsend, A. N. McKenzie, and C. M. Lloyd
The Absence of Interleukin 9 Does Not Affect the Development of Allergen-induced Pulmonary Inflammation nor Airway Hyperreactivity
J. Exp. Med., January 7, 2002; 195(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Louahed, M. Toda, J. Jen, Q. Hamid, J.-C. Renauld, R. C. Levitt, and N. C. Nicolaides
Interleukin-9 Upregulates Mucus Expression in the Airways
Am. J. Respir. Cell Mol. Biol., June 1, 2000; 22(6): 649 - 656.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M.-P. Buisine, L. Devisme, M.-C. Copin, M. Durand-Réville, B. Gosselin, J.-P. Aubert, and N. Porchet
Developmental Mucin Gene Expression in the Human Respiratory Tract
Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 209 - 218.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. Wang, D. J. Lim, J. Han, Y. S. Kim, C. B. Basbaum, and J.-D. Li
Novel Cytoplasmic Proteins of Nontypeable Haemophilus influenzae Up-regulate Human MUC5AC Mucin Transcription via a Positive p38 Mitogen-activated Protein Kinase Pathway and a Negative Phosphoinositide 3-Kinase-Akt Pathway
J. Biol. Chem., January 4, 2002; 277(2): 949 - 957.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the European Respiratory Society.